Literature DB >> 8532902

Tangential breast irradiation with or without internal mammary chain irradiation: results of a randomized trial.

H Kaija1, P Maunu.   

Abstract

UNLABELLED: A prospective randomized study was made of 270 patients with unilateral stage I or II invasive breast cancer treated by segmental resection, axillary dissection and radiation at the University Hospital of Tampere, Finland, between 1989 and 1991. The aim of the study was to determine whether there is any advantage or disadvantage if the internal mammary chains (IMC) are included in the radiation target volume. The medial and lateral two-field technique was used and the target volumes were determined randomly either to include the internal mammary chain (IMC-RT) or not (no-IMC-RT). The prevalence of radiation pneumonitis was 16% and there was no significant difference between the IMC- and no-IMC-groups (18 vs. 14%). Skin reactions were equal in both groups. Lung fibrosis was more common in the IMC-RT group. IN
CONCLUSION: radiation of internal mammary chain after conservative surgery does not lead to an increase in clinically important skin or pulmonary complications. Whether it prevents recurrences or new primaries of the opposite breast is too early to say because of the short follow-up time.

Entities:  

Mesh:

Year:  1995        PMID: 8532902     DOI: 10.1016/0167-8140(95)01607-i

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  12 in total

1.  Can the sentinel lymph node technique affect decisions to offer internal mammary chain irradiation?

Authors:  Jean-Cyril Bourre; Raoul Payan; Delphine Collomb; Céline Gallazzini-Crepin; Alex Calizzano; Marie-Dominique Desruet; Dominique Pasquier; Michel Bolla; Daniel Fagret; Jean-Philippe Vuillez
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-01-14       Impact factor: 9.236

Review 2.  Is internal mammary nodes irradiation as a part of breast cancer postoperative radiotherapy necessary?

Authors:  Zhi-Rui Zhou; Zhao-Zhi Yang; Xiao-Li Yu; Xiao-Mao Guo
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

3.  Novel eradicative high-dose rate brachytherapy for internal mammary lymph node metastasis from breast cancer.

Authors:  Kazushi Kishi; Hirokazu Tanino; Tetsuo Sonomura; Shintaro Shirai; Yasutaka Noda; Morio Sato; Yoshitaka Okamura
Journal:  World J Radiol       Date:  2012-11-28

4.  Unintended irradiation of internal mammary chain - Is that enough?

Authors:  Lucas Gomes Sapienza; Michael Jenwei Chen; Maria José Leite Gomes; David B Mansur
Journal:  Rep Pract Oncol Radiother       Date:  2015-08-11

Review 5.  Postmastectomy radiotherapy in women with breast cancer metastatic to one to three axillary lymph nodes.

Authors:  C I Sartor
Journal:  Curr Oncol Rep       Date:  2001-11       Impact factor: 5.075

Review 6.  Breast cancer (non-metastatic).

Authors:  Justin Stebbing; Geoff Delaney; Alastair Thompson
Journal:  BMJ Clin Evid       Date:  2011-02-08

7.  Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy.

Authors:  Pauline T Truong; Ivo A Olivotto; Timothy J Whelan; Mark Levine
Journal:  CMAJ       Date:  2004-04-13       Impact factor: 8.262

Review 8.  Breast cancer (non-metastatic).

Authors:  Justin Stebbing; Geoff Delaney; Alistair Thompson
Journal:  BMJ Clin Evid       Date:  2007-12-04

9.  The effect of adjuvant radiotherapy on mortality differs according to primary tumor location in women with node-positive breast cancer.

Authors:  Vincent Vinh-Hung; Pauline T Truong; Wolfgang Janni; Nam Phong Nguyen; Georges Vlastos; Gábor Cserni; Melanie E Royce; Wendy A Woodward; Donald Promish; Patricia Tai; Guy Soete; Sabine Balmer-Majno; Bruno Cutuli; Guy Storme; Christine Bouchardy
Journal:  Strahlenther Onkol       Date:  2009-03-28       Impact factor: 3.621

10.  Sentinel lymph node biopsy of the internal mammary chain in breast cancer.

Authors:  E L Postma; S van Wieringen; M G Hobbelink; H M Verkooijen; H J G D van den Bongard; I H M Borel Rinkes; A J Witkamp
Journal:  Breast Cancer Res Treat       Date:  2012-06-08       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.